文献速递重症综合管理与镇静镇痛

重症监护预警平台对内科学病房转入重症监护室患者临床预后的影响:一项真实世界队列研究

[Impact of critical care warning platform on the clinical prognosis of patients transferred from internal medical ward to intensive care unit: a real-world cohort study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2025-01-01
一句话结论真实世界回顾性队列显示,连接重症监护预警平台与内科学病房转入ICU患者住院死亡率降低相关(17.6% vs 25.7%)。

该回顾性队列纳入2022年1月至2024年10月东南大学附属中大医院内科学病房转入ICU的1281例患者,按是否连接重症监护预警平台分为预警组(768例)和常规治疗组(513例)。预警平台实时采集生命体征和治疗数据,自动计算严重程度评分、生成个体化风险评估并触发预警。预警组住院死亡率显著低于常规组(17.6% vs 25.7%,P<0.01),ICU死亡率、28天内机械通气天数和ICU住院天数也显著更低。多因素Logistic回归校正年龄和基础疾病后,使用预警平台与住院死亡率降低显著相关(OR=0.670,95%CI 0.502-0.894,P=0.006)。

要点

  • 内科学病房转入ICU患者中,连接重症监护预警平台者住院死亡率17.6%(135/768),未连接者25.7%(132/513),P<0.01。
  • 校正年龄和基础疾病后,使用预警平台与住院死亡率降低显著相关(OR=0.670,95%CI 0.502-0.894,P=0.006)。
  • 脓毒症转入ICU亚组中,使用预警平台显著降低住院死亡率(OR=0.514,95%CI 0.367-0.722,P<0.001)。
  • 年龄≥70岁患者(OR=0.587,95%CI 0.415-0.831,P=0.003)和合并恶性肿瘤患者(OR=0.124,95%CI 0.046-0.330,P<0.001)中,预警平台显示显著保护作用。
  • 预警组28天内机械通气天数更少[2(1,6)天 vs 2(1,8)天,P<0.05],ICU住院天数更短[3(2,8)天 vs 4(2,10)天,P<0.01],ICU死亡率更低(15.1% vs 21.4%,P<0.01)。

适用人群与场景

  • 2022年1月至2024年10月东南大学附属中大医院内科学病房转入ICU的患者。
  • 按是否连接重症监护预警平台分为预警组(768例)和常规治疗组(513例)。

处置流程与药物剂量

  • 预警组患者连接重症监护预警平台,平台实时采集生命体征和治疗数据,自动计算严重程度评分、生成个体化风险评估并触发预警警报,临床医生据此调整治疗方案。
  • 常规治疗组不连接预警平台,依靠常规临床判断和护理措施进行治疗管理。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入1281例内科学病房转入ICU患者,预警组768例、常规治疗组513例。
  • 主要终点住院死亡率:预警组17.6%(135/768) vs 常规治疗组25.7%(132/513),P<0.01。
  • 次要终点ICU死亡率:预警组15.1%(116/768) vs 常规治疗组21.4%(110/513),P<0.01。
  • 次要终点28天内机械通气天数:预警组2(1,6)天 vs 常规治疗组2(1,8)天,P<0.05。
  • 次要终点ICU住院天数:预警组3(2,8)天 vs 常规治疗组4(2,10)天,P<0.01。
  • 多因素Logistic回归校正年龄和基础疾病后,使用预警平台与住院死亡率降低显著相关(OR=0.670,95%CI 0.502-0.894,P=0.006)。
  • 亚组分析:脓毒症转入ICU患者中使用预警平台显著降低住院死亡率(OR=0.514,95%CI 0.367-0.722,P<0.001);年龄≥70岁患者(OR=0.587,95%CI 0.415-0.831,P=0.003)和合并恶性肿瘤患者(OR=0.124,95%CI 0.046-0.330,P<0.001)中预警平台显示显著保护作用。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(真实世界数据)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,使用重症监护预警平台与内科学病房转入ICU患者住院死亡率降低显著相关,显示其在评估住院患者病情恶化方面具有潜力。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate the impact of critical care warning platform (CWP) on clinical outcomes of patients transferred from internal medical ward to intensive care unit (ICU) based on real-world data.

METHODS: A retrospective cohort study was conducted. The patients transferred from internal medical ward to ICU of Zhongda Hospital, Southeast University, between January 2022 and October 2024, were enrolled. They were divided into critical care warning group and conventional treatment group based on whether they were connected to the CWP. The patients in the critical care warning group were connected to the CWP, which collected real-time vital signs and treatment data. The platform automatically calculated severity scores, generated individualized risk assessments, and triggered warning alerts, allowing clinicians to adjust treatment plans accordingly. The patients in the conventional treatment group were not connected to the CWP and relied on conventional clinical judgment and nursing measures for treatment management. Baseline characteristics [gender, age, body mass index (BMI), admission type, severity score of illness, underlying diseases, and disease type at ICU admission], primary clinical outcome (in-hospital mortality), and secondary clinical outcomes [ICU mortality, length of ICU stay, total length of hospital stay, and mechanical ventilation and continuous renal replacement therapy (CRRT) status] were collected. Multivariate Logistic regression was used to analyze the impact of CWP on in-hospital death, and subgroup analyses were performed based on different patient characteristics.

RESULTS: A total of 1 281 patients were enrolled, with 768 in the critical care warning group and 513 in the conventional treatment group. Compared with the conventional treatment group, the proportion of patients in the critical care warning group with underlying diseases of diabetes and malignancy and transferred to ICU due to sepsis was lowered, however, there were no statistically significant differences in other baseline characteristics between the two groups. Regarding the primary clinical outcome, the in-hospital mortality in the critical care warning group was significantly lower than that in the conventional treatment group [17.6% (135/768) vs. 25.7% (132/513), P < 0.01]. For secondary clinical outcomes, compared with the conventional treatment group, the patients in the critical care warning group had significantly fewer days of mechanical ventilation within 28 days [days: 2 (1, 6) vs. 2 (1, 8), P < 0.05], significantly shorter length of ICU stay [days: 3 (2, 8) vs. 4 (2, 10), P < 0.01], and significantly lower ICU mortality [15.1% (116/768) vs. 21.4% (110/513), P < 0.01]. Multivariate Logistic regression analysis showed that, after adjusting for age and underlying diseases, the use of CWP was significantly associated with a reduction of in-hospital mortality among patients transferred from internal medical ward to ICU [odds ratio (OR) = 0.670, 95% confidence interval (95%CI) was 0.502-0.894, P = 0.006]. Further subgroup analysis revealed that, among patients transferred to ICU due to sepsis, the use of CWP significantly reduced in-hospital mortality (OR = 0.514, 95%CI was 0.367-0.722, P < 0.001). In patients aged ≥ 70 years old (OR = 0.587, 95%CI was 0.415-0.831, P = 0.003) and those with underlying diseases of malignancy (OR = 0.124, 95%CI was 0.046-0.330, P < 0.001), CWP also showed significant protective effects on in-hospital prognosis.

CONCLUSION: The use of CWP is significantly associated with a reduction in in-hospital mortality among patients transferred from internal medical ward to ICU, demonstrating its potential in assessing the deterioration of hospitalized patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wu C, Chen S, Huang L, et al. [Impact of critical care warning platform on the clinical prognosis of patients transferred from internal medical ward to intensive care unit: a real-world cohort study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40814712. doi:10.3760/cma.j.cn121430-20241212-00591

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。